Is the biomarker and meld scores sufficient at this point to continue holding the shares? is this signal enough?
What are the other phase 2 suppose to reveal...much the same?
Looks like we are on track for > 50% share turnover, will be interesting to see if it holds the gains. One would have expected that we are back in the 10-12 range with positive news after the last fiasco.
Market Data 
Markets 
AI
